Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
Any age
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Signed informed consent, postmenopausal females, histological or cytological confirmed oestrogene and/or progesterone (PgR) receptor positive breast cancer, local recurrence or metastasis
You may not be if
Previous systemic endocrine therapy for advanced or recurrent disease; prior fulvestrant therapy
Premenopausal women
Clareo Health | Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy
